why choose us

First received: November 28, 2022

Clinical Trial: The Study of Mesenchymal Stem Cells Treat Autoimmune Pulmonary Alveolar Proteinosis in Vitro

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Pulmonary Alveolar Proteinosis(PAP)

Study Type: Observational


Official Title: The Study of Mesenchymal Stem Cells Treat Autoimmune Pulmonary Alveolar in Vitro

Brief Summary: Autoimmune pulmonary alveolar proteinosis (aPAP) is a respiratory disease characterized by massive deposition of pulmonary surfactant in the alveoli, involving a variety of immune cells and factor disorders. However, there are certain limits in treatment at present. MSCs can improve the microenvironment in the alveoli by regulating immunity, thereby achieving a good therapeutic effect. The purpose of this study is to use the lavage fluid obtained after whole lung lavage with aPAP to isolate alveolar macrophages,…

Read more